MAIA (MAIA Biotechnology) Other Operating Expense : $-0.08 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is MAIA Biotechnology Other Operating Expense?

MAIA Biotechnology's Other Operating Expense for the three months ended in Dec. 2024 was $-0.03 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.08 Mil.

MAIA Biotechnology's quarterly Other Operating Expense increased from Jun. 2024 ($-0.02 Mil) to Sep. 2024 ($-0.01 Mil) but then declined from Sep. 2024 ($-0.01 Mil) to Dec. 2024 ($-0.03 Mil).

MAIA Biotechnology's annual Other Operating Expense declined from Dec. 2022 ($0.79 Mil) to Dec. 2023 ($-0.18 Mil) but then increased from Dec. 2023 ($-0.18 Mil) to Dec. 2024 ($-0.08 Mil).

MAIA Biotechnology Other Operating Expense Historical Data

The historical data trend for MAIA Biotechnology's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MAIA Biotechnology Other Operating Expense Chart

MAIA Biotechnology Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

0.79

-0.18

-0.08

MAIA Biotechnology Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Operating Expense	Get a 7-Day Free Trial												-0.03	-0.02	-0.02	-0.01	-0.03

MAIA Biotechnology Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.08 Mil.

MAIA Biotechnology Other Operating Expense Related Terms

Thank you for viewing the detailed overview of MAIA Biotechnology's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

MAIA Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MAIA Biotechnology Inc (AMEX:MAIA) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

444 West Lake Street, Suite 1700, Chicago, IL, USA, 06060

Website

https://www.maiabiotech.com

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

Executives

Stan Smith	director	444 WEST LAKE STREET, SUITE 1700, CHICAGO IL 60606
Ramiro Guerrero	director	444 WEST LAKE STREET, SUITE 1700, CHICAGO IL 60606
Steven M Chaouki	director	C/O TRANSUNION, 555 WEST ADAMS STREET, CHICAGO IL 60661
Cristian Luput	director	444 WEST LAKE STREET, SUITE 1700, CHICAGO IL 60606
Ngar Yee Louie	director, 10 percent owner	444 WEST LAKE STREET, SUITE 1700, CHICAGO IL 60606
Vlad Vitoc	director, 10 percent owner, officer: Chief Executive Officer	444 WEST LAKE STREET, SUITE 1700, CHICAGO IL 60606
Joseph F Mcguire	officer: Chief Financial Officer	6670 SPRINGLAKE ROAD, KEYSTONE HEIGHTS FL 32656
Jean-manasse Theagene	director	500 PLACE D ARMES, SUITE 1800, MONTREAL A8 H2Y 2W2
Sergei Gryaznov	officer: Chief Scientific Officer	444 WEST LAKE STREET, SUITE 1700, CHICAGO IL 60606
Laurentiu Vlad	director	444 WEST LAKE STREET, SUITE 1700, CHICAGO IL 60606
Mihail Obrocea	officer: Chief Medical Officer	444 WEST LAKE STREET, SUITE 1700, CHICAGO IL 60606